CoChat

Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells

Open access
Wiedemann, Gabriela Maria, Knott, Max Martin Ludwig, Vetter, Viola Katharina, Rapp, Moritz, Haubner, Sascha, Fesseler, Julia, Kühnemuth, Benjamin, Layritz, Patrick, Thaler, Raffael, Kruger, Stephan, Ormanns, Steffen, Mayr, Doris, Endres, Stefan, Anz, David · 2016 · OncoImmunology
Cited by 107

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

In cancer patients, immunosuppression through regulatory T cells (Treg) is a crucial component of tumor immune evasion and contributes to disease progression. Tumor-infiltrating Treg in particular suppress local effector T cell responses and are associated with poor prognosis in tumors such as human pancreatic cancer or hepatocellular carcinoma (HCC). The chemokine CCL22 is known to recruit Treg into the tumor tissue and many types of human tumors are known to express high levels of CCL22. The mechanisms leading to intratumoral secretion of CCL22 are so far unknown. We demonstrate here that intratumoral CCL22 is induced in tumor-infiltrating immune cells through cancer cell-derived interleukin-1 (IL-1α). In pancreatic cancer and HCC, CCL22 is produced by intratumoral dendritic cells, while the cancer cells themselves do not secrete CCL22 in vitro and in vivo. Incubation of human peripheral blood mononuclear cells (PBMC) or murine splenocytes with tumor cells or tumor cell supernatants strongly induced CCL22 secretion in vitro. Tumor cell supernatants contained IL-1 and CCL22 induction in PBMC could be specifically prevented by the IL-1 receptor antagonist anakinra or by transfection of tumor cell lines with IL-1 siRNA, leading to a suppression of Treg migration. In conclusion, we identify here tumor cell-derived IL-1α as a major inducer of the Treg attracting chemokine CCL22 in human cancer cells. Therapeutic blockade of the IL-1 pathway could represent a promising strategy to inhibit tumor-induced immunosuppression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/2162402x.2016.1175794

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 107

Metadata

Authors
Wiedemann, G. M., Knott, M. M. L., Vetter, V. K., Rapp, M., Haubner, S., Fesseler, J., Kühnemuth, B., Layritz, P., Thaler, R., Kruger, S., Ormanns, S., Mayr, D., Endres, S., & Anz, D.
Venue
OncoImmunology
Published
2016-04-25
Volume
5
Issue
9
Pages
e1175794
ISSN
  • 2162-4011 (ISSN-L)
  • 2162-402X
OpenAlex
W2343759513
Cited by
107
References
7
FWCI
2.63
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells. https://app.cochat.ai/papers/10.1080/2162402x.2016.1175794
The paper
Wiedemann, G. M., Knott, M. M. L., Vetter, V. K., Rapp, M., Haubner, S., Fesseler, J., Kühnemuth, B., Layritz, P., Thaler, R., Kruger, S., Ormanns, S., Mayr, D., Endres, S., & Anz, D. (2016). Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells. OncoImmunology. https://doi.org/10.1080/2162402x.2016.1175794

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.